CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
ChangChun High New Technology Industries Company Snapshot
ChangChun High New Technology Industries operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares ChangChun High New Technology Industries with three other companies in this sector in China: Shenzhen Hepalink Pharmaceutical Company Limited (2015 sales of 2.29 billion Chinese Renmimbi [US$334.01 million] of which 100% was Pharmaceutical Manufacturing), Shanxi Zhendong Pharmaceutical Co Ltd (2.26 billion Chinese Renmimbi [US$329.97 million] of which 95% was Medicine Manufacture and Sale), and Shandong Lukang Pharmaceutical (2.41 billion Chinese Renmimbi [US$351.46 million] of which 71% was Human Antibiotic).

Sales Analysis. During the year ended December of 2015, sales at ChangChun High New Technology Industries were 2.37 billion Chinese Renmimbi (US$346.42 million). This is an increase of 6.3% versus 2014, when the company's sales were 2.23 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at ChangChun High New Technology Industries (and since 2010, sales have increased a total of 104%). Sales of Medication saw an increase of 7.2% in 2015, from 1.76 billion Chinese Renmimbi to 1.89 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
ChangChun High New Technology Industries
  Stock Performance Chart for ChangChun High New Technology Industries
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 111.16
(Figures in Chinese Renmimbi)
1 Week -0.8%   13 Weeks -3.6%  
4 Weeks -0.9%   52 Weeks 23.2%  
 
ChangChun High New Technology Industries Key Data:
  Ticker: 000661 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2015 Sales 2,374,717,693
(Year Ending Jan 2016).
Employees: 3,861
  Currency: Chinese Renmimbi Market Cap: 18,909,679,377
  Fiscal Yr Ends: December Shares Outstanding: 170,112,265
  Share Type: A Gu Closely Held Shares: 48,495,094
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.